Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosis
GLS improvement post-treatment confers a significant survival benefit. This study supports GLS as an important marker for risk stratification and cardiac response.
Authors
- Heather Jolie Landau (ORCID: https://orcid.org/0000-0002-3152-1189)
- Katherine Lee Chuy (ORCID: https://orcid.org/0000-0001-6856-2657)
- Xiaoyue Ma (ORCID: https://orcid.org/0000-0003-4932-6450)
- Richard Kar-Hang Cheng (ORCID: https://orcid.org/0000-0001-5994-5998)
- Ji Can Yang (ORCID: https://orcid.org/0000-0003-3238-6246)
- Daniel J. Lenihan (ORCID: https://orcid.org/0000-0001-9458-0154)
- Carol L. Chen
- Anthony F. Yu (ORCID: https://orcid.org/0000-0002-7120-8285)
- Mathew S Mauer
- Kristine Jang (ORCID: https://orcid.org/0009-0002-0444-7056)
- Jennifer E Liu
Institutions
- Northwell Health (US)
- St. Francis Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of Washington (US)
- Cornell University (US)
- North Shore University Hospital (US)
- Stony Brook University Hospital (US)
- Saint Francis Medical Center (US)
- International Society of Nephrology (BE)
- Columbia University (US)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1093/ehjopen/oeaf104
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Cancer Institute